CTOR Competitors & Alternatives

Compare Citius Oncology, Inc. with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

CTOR

Main Stock
$0.78
Tradestie Score
55
Market Cap
$164.52M
Analyst Upside
+413.1%

Top Competitors

47 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
CRON Cronos Group Inc. Common Share
$2.71
$1.02B - 59 Compare
ESPR Esperion Therapeutics, Inc.
$3.14
$584.71M - 61 Compare
ETON Eton Pharmaceutcials, Inc. Common Stock
$27.61
$543.32M - 48 Compare
IRWD Ironwood Pharmaceuticals, Inc. - Class A
$3.24
$237.15M 5.3 52 Compare
BIOA BioAge Labs, Inc. Common Stock
$16.04
$212.23M - 56 Compare
SLXN Silexion Therapeutics Corp Ordinary Shares
$4.86
$11.85M - 58 Compare
DEVS DevvStream Corp. Common Stock
$0.67
$9.95M - 56 Compare
IBO Impact BioMedical, Inc.
$0.54
$7.84M - 50 Compare
PLRZ Polyrizon Ltd. Ordinary Shares
$13.46
$6.53M - 48 Compare
NIVF NewGenIvf Group Limited Class A ordinary shares
$0.84
$4.04M 0.0 49 Compare

Data updated: Jun 03, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

47 stocks in this industry